Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: It is unknown whether insulin therapy can delay or prevent diabetes in nondiabetic relatives of patients with diabetes. METHODS: In a randomized, controlled, nonblinded clinical trial, we screened 84,228 first-degree and second-degree relatives of patients with diabetes for islet-cell antibodies; 3152 tested positive; 2103 of the 3152 underwent genetic, immunologic, and metabolic staging to quantify their risk; 372 of the 2103 had a projected five-year risk of more than 50 percent; 339 of the 372 (median age, 11.2 years) were randomly assigned to undergo either close observation or an intervention that consisted of low-dose subcutaneous ultralente insulin, administered twice daily for a total dose of 0.25 unit per kilogram of body weight per day, plus annual four-day continuous intravenous infusions of insulin. Oral glucose-tolerance tests were performed every six months. Median follow-up was 3.7 years. The primary end point was a diagnosis of diabetes. RESULTS: Diabetes was diagnosed in 69 subjects in the intervention group and 70 subjects in the observation group. The annualized rate of progression to diabetes was 15.1 percent in the intervention group and 14.6 percent in the observation group. The cumulative incidence of diabetes was similar in the two groups (relative risk in the intervention group as compared with the observation group, 0.96). Most subjects in whom diabetes developed were asymptomatic. Progression to diabetes occurred at a faster rate among subjects with abnormal base-line glucose tolerance (22 percent per year) than among those with normal base-line glucose tolerance (10 percent per year, P<0.001). There were no episodes of severe hypoglycemia. The incidence of chemical hypoglycemia, assessed without ascertainment bias, was similar in the two groups. CONCLUSIONS: In persons at high risk for diabetes, insulin at the dosage used in this study does not delay or prevent type 1 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but subgroup analyses suggested a benefit of oral insulin in individuals with the highest titres of insulin auto-antibodies.142,143”
From Type 1 diabetes (2018) · cites this paper as [142]
In the citing paper
“The Diabetes Prevention Trial—Type 1, tested whether oral or parental insulin prevented the development of type 1 diabetes in people who were autoantibody positive. Neither approach reduced diabetes development,”
From Type 1 diabetes (2018) · cites this paper as [142]
In the citing paper
“If one islet autoantibody is found, the test should be repeated and the other autoantibodies should be assayed because the risk of type 1 diabetes increases if two or more autoantibodies are positive (443).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [443]
In the citing paper
“Subcutaneously or intranasally delivered insulin was found to have no preventive effects.39,48”
From The future of type 1 diabetes therapy (2025) · cites this paper as [48]
In the citing paper
“Risk can be assessed by islet cell autoantibodies alone, without the need for evaluating endogenous insulin reserves, as was done for the U.S. DPT-1 trial (306).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [306]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
Verge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1857 · Cited by 420
Cognitive Deficits in Adolescents Who Developed Diabetes Early in Life
Ryan, C., Vega, A., & Drash, A. (1985) · Pediatrics · doi:10.1542/peds.75.5.921 · Cited by 413
Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy
Atkinson, M. A., Maclaren, N. K., & Luchetta, R. (1990) · Diabetes · doi:10.2337/diab.39.8.933 · Cited by 299
Insulin prophylaxis in individuals at high risk of type 1 diabetes
Keller, R. J., Jackson, R. A., Eisenbarth, G. S., & Eisenbarth, G. (1993) · The Lancet · doi:10.1016/0140-6736(93)91215-8 · Cited by 298
Pugliese, A., Gianani, R., Moromisato, R., Awdeh, Z. L., Alper, C. A., Erlich, H. A., Jackson, R. A., & Eisenbarth, G. S. (1995) · Diabetes · doi:10.2337/diab.44.6.608 · Cited by 207
Gotfredsen, C. F., Buschard, K., & Frandsen, E. K. (1985) · Diabetologia · doi:10.1007/bf00703140 · Cited by 205
Vardi, P., Dib, S. A., Tuttleman, M., Connelly, J. E., Grinbergs, M., Radizabeh, A., Riley, W. J., Maclaren, N. K., Eisenbarth, G. S., & Soeldner, J. S. (1987) · Diabetes · doi:10.2337/diab.36.11.1286 · Cited by 192
Attentional Functioning in Children and Adolescents With IDDM
Rovet, J., & Alvarez, M. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.803 · Cited by 153
Cited by
Items 201–300 of 832
Disease-Modifying Therapies in Type 1 Diabetes: A Look into the Future of Diabetes Practice
Greenbaum, C., VanBuecken, D., & Lord, S. (2019) · Drugs · doi:10.1007/s40265-018-1035-y · Cited by 52
Insulin as a key autoantigen in the development of type 1 diabetes
Nakayama, M. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1250 · Cited by 62
Stene, L. C., Witsø, E., Torjesen, P. A., Rasmussen, T., Magnus, P. M., Cinek, O., Wetlesen, T., & Rønningen, K. S. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.04.003 · Cited by 55
Can we prevent diabetic ketoacidosis in children?
Bismuth, E., & Laffel, L. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00286.x · Cited by 54
for the Type 1 Diabetes TrialNet Study Group, Meah, F. A., DiMeglio, L. A., Greenbaum, C. J., Blum, J. S., Sosenko, J. M., Pugliese, A., Geyer, S. M., Xu, P., & Evans‐Molina, C. (2016) · Diabetologia · doi:10.1007/s00125-016-3924-5 · Cited by 58
Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes
Ostrov, D. A., Alkanani, A. K., McDaniel, K. A., Case, S. R., Baschal, E. E., Pyle, L. L., Ellis, S., Pöllinger, B., Seidl, K. J., Shah, V. N., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97739 · Cited by 55
An update on preventive and regenerative therapies in diabetes mellitus
Reimann, M., Bonifacio, E. E., Solimena, M., Schwarz, P. E. H., Ludwig, B., Hanefeld, M., & Bornstein, S. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.11.009 · Cited by 64
Immune therapies of autoimmune diseases: are we approaching a real cure?
Chatenoud, L. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.09.004 · Cited by 54
Vaccination against self to prevent autoimmune disease: the type 1 diabetes model
Harrison, L. C. (2008) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100151 · Cited by 52
T‐cell autoantigens in the non‐obese diabetic mouse model of autoimmune diabetes
Babad, J., Geliebter, A., & DiLorenzo, T. P. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03362.x · Cited by 53
The problems and promises of research into human immunology and autoimmune disease
Roep, B. O., Buckner, J. H., Sawcer, S. J., Toes, R. E. M., & Zipp, F. (2012) · Nature Medicine · doi:10.1038/nm.2626 · Cited by 56
Environmental Triggering of Type 1 Diabetes Autoimmunity
Houeiss, P., Luce, S., & Boîtard, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.933965 · Cited by 61
Gorus, F. K., Balti, E. V., Vermeulen, I., Demeester, S., Van Dalem, A., Costa, O., Dorchy, H., Tenoutasse, S., Mouraux, T., De Block, C., et al. (2012) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2012.04675.x · Cited by 51
Hermann, R., Bartsocas, C. S., Soltész, G., Vazeou, A., Paschou, P., Bozas, E., Malamitsi‐Puchner, A., Simell, O., Knip, M., & Ilonen, J. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.455 · Cited by 50
Miller, M. R., Yin, X., Seifert, J. A., Clare-Salzler, M. J., Eisenbarth, G. S., Rewers, M., & Norris, J. M. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00760.x · Cited by 56
Use of a systems biology approach to understand pancreatic β-cell death in Type 1 diabetes
Eizirik, D. L., Moore, F., Flamez, D., & Ortis, F. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360321 · Cited by 49
Performance of HbA1c as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth
Vehik, K., Cuthbertson, D., Boulware, D., Beam, C. A., Rodriguez, H., Legault, L., Hyytinen, M., Rewers, M. J., Schatz, D. A., Krischer, J. P., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0111 · Cited by 48
Diabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis
Wilkin, T. J. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00343.x · Cited by 48
Coexpression of CD25 and OX40 (CD134) Receptors Delineates Autoreactive T-cells in Type 1 Diabetes
Endl, J., Rosinger, S., Schwarz, B., Friedrich, S.-O., Rothe, G., Karges, W., Schlosser, M., Eiermann, T., Schendel, D. J., & Boehm, B. O. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0387 · Cited by 48
Prevention of type 1 diabetes: the time has come
Sherr, J. L., Sosenko, J. M., Skyler, J. S., & Herold, K. C. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0832 · Cited by 51
Immune intervention in type 1 diabetes
Michels, A. W., & Eisenbarth, G. S. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.07.003 · Cited by 47
Kim, K. S., Kwag, D. S., Hwang, H. S., Lee, E. S., & Bae, Y. H. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00708 · Cited by 49
Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype
Lynch, K. F., Lernmark, B., Merlo, J., Cilio, C., Ivarsson, S., Lernmark, Å., & for the Diabetes Prediction in Skåne (DiPiS) Study Group (2008) · Journal of Perinatology · doi:10.1038/sj.jp.7211912 · Cited by 48
Screening for T1D risk to reduce DKA is not economically viable
Meehan, C., Fout, B. T., Ashcraft, J., Schatz, D., & Haller, M. J. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12313 · Cited by 48
Spanier, J. A., Sahli, N. L., Wilson, J. C., Martinov, T., Dileepan, T., Burrack, A. L., Finger, E. B., Blazar, B. R., Michels, A. W., Moran, A., et al. (2017) · Diabetes · doi:10.2337/db17-0666 · Cited by 47
MARUYAMA, T., SHIMADA, A., KANATSUKA, A., KASUGA, A., TAKEI, I., YOKOYAMA, J., & KOBAYASHI, T. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1288.060 · Cited by 46
Achenbach, P., Warncke, K., Reiter, J., Williams, A. J. K., Ziegler, A., Bingley, P. J., & Bonifacio, E. E. (2006) · Diabetologia · doi:10.1007/s00125-006-0451-9 · Cited by 51
Prediabetes: prediction and prevention trials
Vendrame, F., & Gottlieb, P. A. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2003.12.006 · Cited by 45
The DPT‐1 trial: a negative result with lessons for future type 1 diabetes prevention
Pozzilli, P. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.316 · Cited by 45
Sosenko, J. M., Skyler, J. S., Mahon, J., Krischer, J. P., Beam, C. A., Boulware, D. C., Greenbaum, C. J., Rafkin, L. E., Cowie, C., Cuthbertson, D., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0011 · Cited by 44
Boîtard, C. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.10.003 · Cited by 52
Autoantibodies to IA-2β improve diabetes risk assessment in high-risk relatives
Achenbach, P., Bonifacio, E. E., Williams, A. J. K., Ziegler, A., Gale, E. A. M., Bingley, P. J., & ENDIT Group (2008) · Diabetologia · doi:10.1007/s00125-007-0912-9 · Cited by 48
Trials in type 1 diabetes: Antigen-specific therapies
Coppieters, K. T., Harrison, L. C., & von Herrath, M. G. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.02.002 · Cited by 46
Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals
TePas, E. C., Hoyte, E. G., McIntire, J. J., & Umetsu, D. T. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61706-1 · Cited by 48
Barker, J. M., McFann, K., Harrison, L. C., Fourlanos, S., Krischer, J. P., Cuthbertson, D. D., Chase, H. P., & Eisenbarth, G. S. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.09.033 · Cited by 44
Belgian Diabetes Registry, Decochez, K., Truyen, I., der Auwera, B. J. R. V., Weets, I., Vandemeulebroucke, E., Leeuw, I. H. D., Keymeulen, B., Mathieu, C., Rottiers, R., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1702-x · Cited by 52
CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications
Chatenoud, L. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.09.011 · Cited by 44
Antigen-Specific Therapeutic Approaches in Type 1 Diabetes
Clemente‐Casares, X., Tsai, S. J., Huang, C., & Santamaría, P. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007773 · Cited by 51
International Comparison of C-Peptide Measurements
Wiedmeyer, H.-M., Polonsky, K. S., Myers, G. L., Little, R. R., Greenbaum, C. J., Goldstein, D. E., & Palmer, J. P. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.081570 · Cited by 42
The future of type 1 diabetes therapy
Ziegler, A.-G., Cengiz, E., & Kay, T. W. H. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01438-2 · Cited by 42
Latent autoimmune diabetes in adults (LADA) in Asian and European populations
Kumar, A., & de Leiva, A. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2890 · Cited by 46
Immune Mechanisms and Pathways Targeted in Type 1 Diabetes
Jacobsen, L. M., Newby, B. N., Perry, D. J., Posgai, A. L., Haller, M. J., & Brusko, T. M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1066-5 · Cited by 45
Sosenko, J. M., Skyler, J. S., Palmer, J. P., Krischer, J. P., Cuthbertson, D. D., Yu, L., Schatz, D., Orban, T., Eisenbarth, G. S., & Groups, D. P. T. 1. A. T. 1. D. T. S. (2011) · Diabetes Care · doi:10.2337/dc11-0981 · Cited by 42
Can We Change the Course of Beta-Cell Destruction in Type 1 Diabetes?
Gale, E. A. M. (2002) · New England Journal of Medicine · doi:10.1056/nejm200205303462211 · Cited by 43
Robert, S., & Steidler, L. (2014) · Microbial Cell Factories · doi:10.1186/1475-2859-13-s1-s11 · Cited by 42
Combination immunotherapy for type 1 diabetes
Bone, R. N., & Evans-Molina, C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0878-z · Cited by 41
Ylescupidez, A., Speake, C., Pietropaolo, S. L., Wilson, D. M., Steck, A. K., Sherr, J. L., Gaglia, J. L., Bender, C., Lord, S. M., & Greenbaum, C. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad472 · Cited by 46
New and future immunomodulatory therapy in type 1 diabetes
Tooley, J., Waldron-Lynch, F., & Herold, K. C. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.01.001 · Cited by 47
A historical view from thirty eventful years of immunotherapy in autoimmune diabetes
Bach, J.-F., & Chatenoud, L. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.07.009 · Cited by 41
Kwiatkowski, A. J., Stewart, J. M., Cho, J. J., Avram, D., & Keselowsky, B. G. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000164 · Cited by 44
Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients
Vandemeulebroucke, E., Gorus, F., Decochez, K., Weets, I., Keymeulen, B., Block, C. E. M. D., Tits, J., PIPELEERS, D. G., & Mathieu, C. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.02.005 · Cited by 45
Schatz, D., Cuthbertson, D. D., Atkinson, M. A., Clare-Salzler, M. J., Winter, W. E., MUIR, A. B., Silverstein, J. H., Cook, R., Maclaren, N. K., She, J., et al. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00047.x · Cited by 41
The Main Events in the History of Diabetes Mellitus
Zajac, J., Shrestha, A., Patel, P., & Poretsky, L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_1 · Cited by 60
Chéramy, M., Skoglund, C., Johansson, I., Ludvigsson, J., Hampe, C. S., & Casas, R. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.06.001 · Cited by 42
Antigen-Based Vaccination and Prevention of Type 1 Diabetes
Harrison, L. C., Wentworth, J. M., Zhang, Y., Bandala‐Sanchez, E., Böhmer, R. M., Neale, A. M., Stone, N. L., Naselli, G., Bosco, J. J., Auyeung, P., et al. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0415-7 · Cited by 42
Risk Factors and Primary Prevention Trials for Type 1 Diabetes
Wu, Y., Ding, Y., Gao, J. J., Tanaka, Y., & Zhang, W. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6610 · Cited by 62
Butty, V., Campbell, C., Mathis, D., Benoist, C., & the DPT-1 Study Group (2008) · Diabetes · doi:10.2337/db07-1736 · Cited by 41
Understanding Pre-Type 1 Diabetes: The Key to Prevention
Jacobsen, L. M., Haller, M. J., & Schatz, D. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00070 · Cited by 47
Cabrera, S. M., Colvin, S. C., Tersey, S. A., Maier, B., Nadler, J. L., & Mirmira, R. G. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12068 · Cited by 41
Immunotherapy for the Prevention and Treatment of Type 1 Diabetes
Bresson, D., & von Herrath, M. (2009) · Diabetes Care · doi:10.2337/dc09-0373 · Cited by 42
Minimizing Risks: The Ethics of Predictive Diabetes Mellitus Screening Research in Newborns
Ross, L. F. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.1.89 · Cited by 44
Screening and Prevention of Type 1 Diabetes: Where Are We?
Simmons, K. M., & Sims, E. K. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad328 · Cited by 45
What causes type 1 diabetes? Lessons from animal models
Buschard, K. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02765.x · Cited by 44
Immunotherapy for type 1 diabetes
Frumento, D., Nasr, M. B., Essawy, B. E., D’Addio, F., Zuccotti, G., & Fiorina, P. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0641-y · Cited by 40
Simmons, K., Sosenko, J. M., Warnock, M. V., Geyer, S., Ismail, H., Larsson, H. E., & Steck, A. (2020) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/clinem/dgaa592 · Cited by 25
You, S., Poulton, L. D., Cobbold, S. P., Liu, C., Rosenzweig, M., Ringler, D. J., Lee, W.-H., Segovia, B., Bach, J., Waldmann, H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007848 · Cited by 42
Eisenbarth, G. S., & Buse, J. B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00032-8 · Cited by 42
Immunotherapy for the Prevention and Treatment of Type 1 Diabetes
Goudy, K., & Tisch, R. (2005) · International Reviews of Immunology · doi:10.1080/08830180500379721 · Cited by 39
Sosenko, J. M., Skyler, J. S., Krischer, J. P., Greenbaum, C. J., Mahon, J., Rafkin, L. E., Cuthbertson, D., Cowie, C., Herold, K., Eisenbarth, G., et al. (2010) · Diabetes · doi:10.2337/db10-0534 · Cited by 38
Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials
Nathan, B. M., Boulware, D. C., Geyer, S. M., Atkinson, M. A., Colman, P. G., Goland, R., Russell, W. E., Wentworth, J. M., Wilson, D. M., Evans‐Molina, C., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0916 · Cited by 38
Eising, S., Svensson, J., Skogstrand, K., Nilsson, A., Lynch, K. F., Andersen, P. S., Lernmark, Å., HOUGAARD, D. M., Pociot, F., Nørgaard‐Pedersen, B., et al. (2007) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2007.00846.x · Cited by 40
Antigen-based immunotherapy for autoimmune disease: current status
Ponda, P., & Hirsch, D. (2014) · ImmunoTargets and Therapy · doi:10.2147/itt.s49656 · Cited by 41
Ludvigsson, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051598 · Cited by 38
Phases of diabetes in children and adolescents
Couper, J., & Donaghue, K. C. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00574.x · Cited by 50
Regulatory T cells and type 1 diabetes
Homann, D., & von Herrath, M. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.03.020 · Cited by 37
Redondo, M. J., Babu, S., Zeidler, A., Orban, T., Yu, L., Greenbaum, C., Palmer, J. P., Cuthbertson, D., Eisenbarth, G. S., Krischer, J. P., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1695 · Cited by 37
Xu, P., Beam, C. A., Cuthbertson, D., Sosenko, J. M., Skyler, J. S., Krischer, J. P., & the DPT-1 Study Group (2012) · Diabetes Care · doi:10.2337/dc12-0183 · Cited by 37
Psychological Impact of Screening and Prediction in Type 1 Diabetes
Johnson, S. B. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0208-9 · Cited by 41
Diagnosis, Therapy and Follow-up of Diabetes Mellitus in Children and Adolescents
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0869-0210 · Cited by 38
Wherrett, D. K., & Daneman, D. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.08.006 · Cited by 46
Franke, B., Galloway, T. S., & Wilkin, T. J. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.554 · Cited by 41
To boldly go—or to go too boldly? The accelerator hypothesis revisited
Gale, E. A. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0726-9 · Cited by 39
Bediaga, N. G., Suen, C. S. N. L. W., Haller, M. J., Gitelman, S. E., Evans‐Molina, C., Gottlieb, P. A., Hippich, M., Ziegler, A., Lernmark, Å., DiMeglio, L. A., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05523-2 · Cited by 36
2011 Update: antigen-specific therapy in type 1 diabetes
Michels, A. W., & von Herrath, M. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32834803ae · Cited by 38
Antigen-Based Immune Therapeutics for Type 1 Diabetes: Magic Bullets or Ordinary Blanks?
Čulina, S., Boîtard, C., & Mallone, R. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/286248 · Cited by 40
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Liu, J., Ting, J. P., Al-Azzam, S., Ding, Y., & Afshar, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062805 · Cited by 40
Approaches in type 1 diabetes research: A status report
Rao, V., Raha, O., Chowdhury, S., Dasgupta, S., Raychaudhuri, P., Sarkar, B., & Raju, P. (2009) · International Journal of Diabetes in Developing Countries · doi:10.4103/0973-3930.53126 · Cited by 36
Barker, J. M., McFann, K., Orban, T., & on behalf of DPT-1 Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0694-0 · Cited by 35
Antigen-Based Therapy for the Treatment of Type 1 Diabetes
Tian, J., & Kaufman, D. L. (2009) · Diabetes · doi:10.2337/db09-0451 · Cited by 37
Measurement of pancreatic islet cell proliferation by heavy water labeling
Chen, S., Turner, S., Tsang, E., Stark, J., Turner, H., Mahsut, A., Keifer, K., Goldfinger, M., & Hellerstein, M. K. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00375.2007 · Cited by 34
Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
Pham, M. N., von Herrath, M. G., & Vela, J. L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00651 · Cited by 38
Vicinanza, A., Messaaoui, A., Tenoutasse, S., & Dorchy, H. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12864 · Cited by 38
Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children
Torun, A., Hupalowska, A., Trzonkowski, P., Kierkuś, J., & Pyrzyńska, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642166 · Cited by 41
T cells in the pathogenesis of type 1 diabetes
Mallone, R., & Endert, P. V. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0019-9 · Cited by 34
MECHANISMS IN ENDOCRINOLOGY: Insulin and type 1 diabetes: immune connections
Čulina, S., Brezar, V., & Mallone, R. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0693 · Cited by 44
A Key to T1D Prevention: Screening and Monitoring Relatives as Part of Clinical Care
Greenbaum, C. J. (2021) · Diabetes · doi:10.2337/db20-1112 · Cited by 36
Lessons and gaps in the prediction and prevention of type 1 diabetes
Mameli, C., Triolo, T. M., Chiarelli, F., Rewers, M., Zuccotti, G., & Simmons, K. M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106792 · Cited by 37
Şanlioğlu, A. D., Griffith, T. S., Omer, A., Dirice, E., Sarı, R., Altunbaş, H., Balcı, M. K., & Şanlıoğlu, S. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21677 · Cited by 32
Shigihara, T., Shimada, A., Oikawa, Y., Yoneyama, H., Kanazawa, Y., Okubo, Y., Matsushima, K., Yamato, E., Miyazaki, J., Kasuga, A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8401 · Cited by 40
Kim, D.-H., Lee, J.-C., Lee, M., Kim, K.-W., & Lee, M.-S. (2012) · Diabetologia · doi:10.1007/s00125-012-2723-x · Cited by 32
Metadata
- Authors
- Diabetes Prevention Trial–Type 1 Diabetes Study Group
- Affiliations
- University of Miami (US)
- Corresponding author
- Diabetes Prevention Trial–Type 1 Diabetes Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-05-30
- Volume
- 346
- Issue
- 22
- Pages
- 1685-1691
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W614574849
- Cited by
- 836
- References
- 30
- Citations by year
- 2026: 9 · 2025: 22 · 2024: 24 · 2023: 21 · 2022: 20 · 2021: 32 · 2020: 21 · 2019: 21 · 2018: 22 · 2017: 27 · 2016: 26 · 2015: 34 · 2014: 30 · 2013: 38 · 2012: 42
- FWCI
- 28.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (UC4DK117009)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 1 diabetes, insulin therapy, diabetes prevention, relatives of diabetic patients, islet cell antibodies, ultralente insulin, continuous intravenous insulin infusion, glucose tolerance, hypoglycemia, disease progression
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Diabetes Mellitus, Type 1, Family, Female, Glucose Tolerance Test, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Islets of Langerhans, Male, Middle Aged, Risk Factors, Treatment Failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.